Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 157,328 | 141,346 | 134,395 | 130,113 | 117,609 |
| Receivables | 48,002 | 46,624 | 41,510 | 37,749 | 35,414 |
| Inventories | 22,039 | 15,331 | 16,587 | 13,751 | 11,269 |
| Income taxes - deferred | N/A | N/A | N/A | 94 | 167 |
| TOTAL | $231,008 | $207,140 | $195,733 | $184,236 | $167,703 |
| Non-Current Assets | |||||
| PPE Net | 2,002 | 1,761 | 2,002 | 1,826 | 2,056 |
| Investments And Advances | 724 | 953 | 794 | 2,718 | 0 |
| Intangibles | 31,592 | 31,097 | 30,838 | 32,101 | 32,251 |
| Other Non-Current Assets | 12,285 | 12,527 | 12,531 | 12,480 | 12,510 |
| TOTAL | $46,603 | $46,338 | $46,165 | $49,125 | $46,817 |
| Total Assets | $277,611 | $253,478 | $241,898 | $233,361 | $214,520 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,066 | 1,967 | 3,645 | 4,736 | 2,600 |
| Accrued Expenses | 20,561 | 18,048 | 22,796 | 19,882 | 18,763 |
| TOTAL | $27,627 | $20,015 | $26,441 | $24,618 | $21,397 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 78 | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 34 |
| Other Non-Current Liabilities | 117 | 87 | 92 | 0 | 114 |
| TOTAL | $117 | $87 | $92 | $78 | $114 |
| Total Liabilities | $27,744 | $20,102 | $26,533 | $24,696 | $21,511 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,192 | 51,732 | 51,506 | 51,054 | 49,939 |
| Common Shares | 52 | 52 | 51 | 51 | 50 |
| Retained earnings | -61,120 | -73,302 | -87,765 | -94,176 | -104,292 |
| Other shareholders' equity | -902 | -1,139 | -1,520 | 1,357 | 1,480 |
| TOTAL | $249,867 | $233,376 | $215,365 | $208,665 | $193,009 |
| Total Liabilities And Equity | $277,611 | $253,478 | $241,898 | $233,361 | $214,520 |